Literature DB >> 10630687

The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications.

C C Chiueh1, P Rauhala.   

Abstract

Recent results demonstrated that S-nitrosoglutathione (GSNO) and nitric oxide (*NO) protect brain dopamine neurons from hydroxyl radical (*OH)-induced oxidative stress in vivo because they are potent antioxidants. GSNO and *NO terminate oxidant stress in the brain by (i) inhibiting iron-stimulated hydroxyl radicals formation or the Fenton reaction, (ii) terminating lipid peroxidation, (iii) augmenting the antioxidative potency of glutathione (GSH), (iv) mediating neuroprotective action of brain-derived neurotrophin (BDNF), and (v) inhibiting cysteinyl proteases. In fact, GSNO--S-nitrosylated GSH--is approximately 100 times more potent than the classical antioxidant GSH. In addition, S-nitrosylation of cysteine residues by GSNO inactivates caspase-3 and HIV-1 protease, and prevents apoptosis and neurotoxicity. GSNO-induced antiplatelet aggregation is also mediated by S-nitrosylation of clotting factor XIII. Thus the elucidation of chemical reactions involved in this GSNO pathway (GSH GS* + *NO-->[GSNO]-->GSSG + *NO-->GSH) is necessary for understanding the biology of *NO, especially its beneficial antioxidative and neuroprotective effects in the CNS. GSNO is most likely generated in the endothelial and astroglial cells during oxidative stress because these cells contain mM GSH and nitric oxide synthase. Furthermore, the transfer of GSH and *NO to neurons via this GSNO pathway may facilitate cell to neuron communications, including not only the activation of guanylyl cyclase, but also the nitrosylation of iron complexes, iron containing enzymes, and cysteinyl proteases. GSNO annihilates free radicals and promotes neuroprotection via its c-GMP-independent nitrosylation actions. This putative pathway of GSNO/GSH/*NO may provide new molecular insights for the redox cycling of GSH and GSSG in the CNS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10630687     DOI: 10.1080/10715769900301211

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  22 in total

1.  S-Nitrosoglutathione administration ameliorates cauda equina compression injury in rats.

Authors:  Anandakumar Shunmugavel; Mushfiquddin Khan; Marcus M Martin; Anne G Copay; Brian R Subach; Thomas C Schuler; Inderjit Singh
Journal:  Neurosci Med       Date:  2012-09-25

2.  Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals.

Authors:  C C Chiueh; T Andoh; A R Lai; E Lai; G Krishna
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

3.  Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI.

Authors:  Mushfiquddin Khan; Anandakumar Shunmugavel; Tajinder S Dhammu; Hamza Khan; Inderjit Singh; Avtar K Singh
Journal:  J Neurosci Res       Date:  2018-07-19       Impact factor: 4.164

4.  S-nitrosoglutathione prevents experimental cerebral malaria.

Authors:  Graziela M Zanini; Yuri C Martins; Pedro Cabrales; John A Frangos; Leonardo J M Carvalho
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-06       Impact factor: 4.147

Review 5.  Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies.

Authors:  Changgong Wu; Andrew M Parrott; Cexiong Fu; Tong Liu; Stefano M Marino; Vadim N Gladyshev; Mohit R Jain; Ahmet T Baykal; Qing Li; Shinichi Oka; Junichi Sadoshima; Annie Beuve; William J Simmons; Hong Li
Journal:  Antioxid Redox Signal       Date:  2011-06-08       Impact factor: 8.401

6.  Stimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion.

Authors:  Harutoshi Sakakima; Mushfiquddin Khan; Tajinder S Dhammu; Anandakumar Shunmugavel; Yoshihiro Yoshida; Inderjit Singh; Avtar K Singh
Journal:  Restor Neurol Neurosci       Date:  2012       Impact factor: 2.406

7.  Targeting the nNOS/peroxynitrite/calpain system to confer neuroprotection and aid functional recovery in a mouse model of TBI.

Authors:  Mushfiquddin Khan; Tajinder S Dhammu; Fumiyo Matsuda; Balasubramaniam Annamalai; Tejbir Singh Dhindsa; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2015-11-17       Impact factor: 3.252

8.  S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.

Authors:  Narender Nath; Osamu Morinaga; Inderjit Singh
Journal:  J Neuroimmune Pharmacol       Date:  2010-01-21       Impact factor: 4.147

9.  STAT3 regulation by S-nitrosylation: implication for inflammatory disease.

Authors:  Jinsu Kim; Je-Seong Won; Avtar K Singh; Anand K Sharma; Inderjit Singh
Journal:  Antioxid Redox Signal       Date:  2014-02-14       Impact factor: 8.401

10.  Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology.

Authors:  Monika Zaręba-Kozioł; Agnieszka Szwajda; Michał Dadlez; Aleksandra Wysłouch-Cieszyńska; Maciej Lalowski
Journal:  Mol Cell Proteomics       Date:  2014-06-03       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.